ArticleFrontiers in oncology2014

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin.

David A Alagpulinsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.